Lantern Pharma (LTRN) Reports Positive Efficacy Data of LP-284 in Hematologic Cancers

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 8/28/2026

1. WDAY
2. ESTC
3. AFRM
4. RBRK
5. S
6. MRVL
7. DG
8. GAP
9. ULTA
10. ADSK

Go back to Lantern Pharma (LTRN) Reports Positive Efficacy Data of LP-284 in Hematologic Cancers
(NASDAQ: LTRN) Delayed: 2.16 --0 (-0%)
Previous Close $2.16    52 Week High $ 
Open $2.16    52 Week Low $ 
Day High $2.16    P/E N/A 
Day Low $2.16    EPS $ 
Volume 475